Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Orchestra BioMed to Participate in Jefferies London Healthcare Conference
-
Nano Dimension Sends Letter to Shareholders
-
Sysco Becomes Official Partner of the MICHELIN Guide Texas Ceremony
-
iMD Companies and Its Subsidiary Riize Health Announce Official Product Line Launch of Riize Hair
-
MedSource Labs Announces Groundbreaking Digital Training Assets for IV Catheters
-
Clip Money Inc. Expands Partnership with CBL Properties to Bring On-Site Cash Deposit Services to 36 Malls
-
LiveOne (Nasdaq: LVO) Reports Q2 Fiscal 2025 Results
-
Inventory and Pricing Drive Gains in Sales Satisfaction but Other Areas Have Modest Improvement, J.D. Power Finds
-
GE HealthCare to Host its 2024 Investor Day on November 21
-
Aventon Ranked #1 in the TIME World’s Best Brands 2024
-
DiagnaMed Files U.S. Patent Application for Novel Methods of Producing Molecular Hydrogen
-
Breaking Barriers: New Explainer on the Science of Addiction Available in 12 Languages
-
Armlogi Announces New 480,000 Square Foot Warehouse Lease in Ontario, CA
-
Annual International Conference on ADHD Hosted by CHADD, ADDA and ACO Provides Trusted Information, Guidance and Support to the ADHD Community
-
Los Angeles County Adds Genasys ALERT Emergency Warning and Notification to Genasys EVAC Emergency Management and Planning
-
Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting
-
Spur Therapeutics to Participate in B. Riley Securities’ Next-Gen Tissue Delivery Modalities Virtual Summit
-
Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Sunrise Realty Trust Announces the Successful Closing of a Senior Revolving Credit Facility up to $200 Million with an Initial $50 Million Commitment from East West Bank
-
Regency Centers Increases Common Stock Dividend by 5.2%
-
Aprea Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024
-
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Duos Edge AI Acquires Additional Edge Data Centers
-
Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results
-
Celularity Raises Full Year 2024 Guidance as Expected Net Sales Through October Reach $44.4 Million
-
Best Law Firms List Recognizes Hilgers Graben as One of Nation’s Top Law Firms for 2025
-
Better Choice Company to Present at the Sidoti Micro Cap 2024 Virtual Conference
-
Skyharbour Commences Fall Diamond Drilling Program at its Russell Lake Uranium Project, Saskatchewan
-
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
-
Absci to Host R&D Day on December 12, 2024
-
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
-
SonicWall Unveils TZ80: Empowering Service Providers to Deliver Comprehensive Security, Remote Access and Networking Solutions for Branch Offices and SOHO
-
WK Kellogg Co Announces Third Quarter Financial Results and Raises 2024 Adjusted EBITDA Guidance
-
Ryvu Therapeutics Reports 2024 Q3 Financial Results and Provides Corporate Update
-
Top Features to Look for in an NSFW AI Chatbot in 2025
-
Cassava Sciences Reports Q3 2024 Financial and Operating Results
-
Vericel Reports Third Quarter 2024 Financial Results
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
Waterfall Network Becomes the Most Scalable EVM-based Smart Contract Platform According to Recent Performance Tests
-
SmartLedger Launches WinScope: A Transparent, AI-Driven Decentralized Autonomous Sports Prediction Platform Empowering Bettors with Real-Time Insights and Community Governance
-
Burford Capital Reports Third Quarter 2024 Results
-
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
-
ParaZero Secured $187,000 Purchase Order for Cutting-Edge Drone Safety Systems, Moving Closer to Mass-Production
-
Regenerative Medical Technology Group Announces the Opening of New Clinic in Dubai on November 23
-
Volatus Aerospace Inc. Corporate Update
-
Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit
-
Burford Statement re YPF Matter
-
Next Hydrogen to demonstrate electrolyzers for the aviation industry in collaboration with Pratt & Whitney under INSAT program
-
Next Hydrogen to demonstrate electrolyzers for the aviation industry in collaboration with Pratt & Whitney under INSAT program
